Healthsouth Corp: (NYSE: HLS)

$30.59

0.23 (0.76%)

Volume 461,115

May 20 04:02 PM ET

Zacks Rank: 1-Strong Buy

Zacks Rank	Definition	Annualized Return
#1	Strong Buy	26.6%
#2	Buy	18.71%
#3	Hold	10.12%
#4	Sell	4.32%
#5	Strong Sell	2.16%
S&P	500	9.93%

Overview Quote

            Stock Activity
        
		Day Low - High
		30.36 - 30.73
	
		52wk Low - High
		18.44 - 30.73
	
		Previous Close
		30.36
	
		Avg. Volume
		526,881
	
		Industry
		MED-OUTP/HM CRE
	
		Market Cap
		2.93 B
	
		Div - Yield
		0.00 - 0.00
	
		Beta
		1.64
	
		PE (Forward)
		17.29
	
		Current Year Est.
		1.76
	
		Quarterly Earnings ESP 
		2.38%
	
Earnings ESP (Expected Surprise Prediction) is Zacks' proprietary methodology for determining which stocks have the best chance to surprise with their next earnings announcement. The Earnings ESP shows the percentage difference between the Most Accurate Estimate and the Consensus.

                Premium research
            
		Zacks Rank  Short-Term: 1-3 Months
                                                                
                                                                Zacks #1 Rank Strong Buys
                                                                
                                                            This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below. 

                                                                        Zacks Rank
                                                                        Definition
                                                                        Annualized Return
                                                                    
                                                                        #1
                                                                        Strong Buy
                                                                        26.6%
                                                                    
                                                                        #2
                                                                        Buy
                                                                        18.71%
                                                                    
                                                                        #3
                                                                        Hold
                                                                        10.12%
                                                                    
                                                                        #4
                                                                        Sell
                                                                        4.32%
                                                                    
                                                                        #5
                                                                        Strong Sell
                                                                        2.16%
                                                                    
                                                                        S&P
                                                                        500
                                                                        9.93%
                                                                    
Zacks Rank Education - Learn more about the Zacks Rank
Zacks Rank Home - All Zacks Rank resources in one place
Zacks Premium - The only way to get access to the Zacks Rank
                                                        
		1
Strong Buy

		Zacks Recommendation  Long-Term: 6+ Months
                                                                
                                                                All Outperform Rated Stocks
                                                                
                                                            Zacks Recommendations are an excellent predictor of stock price movement over a 6+ month time frame. The recommendations come from the Zacks Equity Research group which combines the Zacks Rank with the insights from their team of over 50 equity analysts. The result is superior long term stock ratings.
The Zacks Recommendations are split into 3 groups: Buy, Hold and Sell. Our Buy recommendations have generated returns of 34.4% in 2006, and 16.69% in 2007. When Zacks Premium members click on the recommendation it will launch them to the Zacks Equity Research report for the stock.    More on these reports below.

                                                                    Difference Between Zacks Rank and Zacks Recommendation

                                                                    Zacks Equity Research Home
Zacks Premium - The only way to get access to Zacks Recommendations
                                                                
		Outperform
	
		Zacks Industry Rank Which industries are set to outperform or underperform the market? You'll find the answer here. We have broken down all industries into over 200 classifications. Then ranked these industries using the most powerful indicator we know (the Zacks Rank). The higher the industry rank, the better the industry should perform in the future. Once you have found an attractive industry then check out the Rank in Industry to find the best stocks within the industry.
When Zacks Premium members click on the Zacks Industry Rank link they will see the full listing of industries and their current rankings.

                                                                About Zacks Industry Rank

                                                                Zacks Industry Rank - All current industry ranks. 

                                                                Zacks Premium - The only way to get access to the Zacks Industry Rank
                                                            
		201 out of 265
	
		Equity Research Report The Zacks Recommendations and Zacks Target Prices are just two of the valuable resources you'll find in the reports created by the Zacks Equity Research group. When Zacks Premium members click on this link they will taken to a page that gives them access to the Zacks Equity Research report for the stock.

                                        Zacks Equity Research Home
                                        Zacks Premium - The only way to get access to Zacks Recommendations
                                    
Updated as of 05/10/2013

		PREMIUM
	
    (  = Change in last 30 days) 
Get all our stock ratings and recommendations with a Free Trial to Zacks Premium Start Free Trial 
Zacks Premium Home | Zacks Rank Stock Education

                Key Earnings Data
            
                            PE (Forward)
                            17.29
                        
                            PEG Ratio
                            1.28
                        
                            Current Year Est.
                            1.76
                        
                            Current Quarter Estimate
                            0.42
                        
                            Most Accurate Estimate
                            0.43
                        
                            Earnings ESP 
                            2.38%
                        
                            Next Earnings Report Date
                            07-25-2013
                        
                            EPS Last Year
                            1.71
                        
                            Expected Earnings Growth
                            13.50%
                        
Earnings ESP (Expected Surprise Prediction) is Zacks' proprietary methodology for determining which stocks have the best chance to surprise with their next earnings announcement. The Earnings ESP shows the percentage difference between the Most Accurate Estimate and the Consensus.

            Company Description
        
HEALTHSOUTH Corp. is the one of the nation's largest providers of outpatient surgery and rehabilitative healthcare services. The company provides these services through its national network of inpatient and outpatient healthcare facilities, including inpatient and outpatient rehabilitation facilities, outpatient surgery centers, diagnostic centers, occupational medicine centers, medical centers and other healthcare facilities.   
Full HLS Company Report

        
NYSE data is at least 20 minutes delayed.
NASDAQ data is at least 15 minutes delayed.

            Interactive Java Charting | Fundamental Charts
        
            <a href="#"><img id="dart_image_1" src="http://b7d61a7c6b8c307bf531-a92a66b9587e2a0aa805bd4e70b98407.r95.cf2.rackcdn.com/images/zacks/logos/zacks_logo_230x76.png" width="336" height="280" border="0" alt="" /></a>        
Turn Earnings Surprises into quick profits.
 
HLS Chart  by YCharts

Earnings Estimates

	Current Qtr (06/2013)	Next Qtr (09/2013)	Current Year (12/2013)	Next Year (12/2014)
Average Estimate	0.42	0.41	1.76	1.92
Number of Estimates	7	7	8	8
Low Estimate	0.40	0.38	1.70	1.84
High Estimate	0.47	0.44	1.86	NA
Year Ago EPS	0.39	0.39	1.68	1.76
EPS Growth	8.42%	4.76%	4.54%	9.18%

More HLS Estimates

Average Earnings Estimates for HLS

EPS Growth for HLS

Industry Analysis

Name	Symbol	Previous Close
HEALTHSOUTH CP	HLS	30.36
ADDUS HOMECARE	ADUS	15.37
AMSURG CORP	AMSG	36.38
BRAIN RESOURCE	BRRZY	0.00
CHINA CORD BLD	CO	2.82
DAVITA INC	DVA	128.14
LHC GROUP LLC	LHCG	22.56
QUEST DIAGNOSTC	DGX	60.69
RADNET INC	RDNT	2.54
UNIVTY GEN HLTH	UGHS	0.58

Sector:Medical>> Industry:MED-OUTP/HM CRE

COMPARE TICKER vs. Its Peers

Zacks Commentary

GHDX Reports Loss, Beats on Revs

May 13, 2013

Quest Diagnostics Upgraded to Neutral

May 10, 2013

Weak 1Q Earnings for Gentiva

May 09, 2013

DaVita Reports Strong 1Q Earnings

May 08, 2013

HAE Beats on Earnings, Revs in Line

May 03, 2013

LIFE Beats Earnings, Margins Low

May 03, 2013

Haemonetics Closes Hemerus Acquisition

May 02, 2013

Qiagen Misses Earnings, Guides Low

May 01, 2013

More HLS Zacks Commentary

Financials

EPS TTM	1.71
Sales	2,162
Net Income	186
Price/Earnings	17.75
Price/Book	13.09
Price/Cash Flow	11.99
Price/Sales	1.33

More HLS Financials

News

Recent 52-Week High Exceeded in Shares of HealthSouth (HLS) - Financial News Netwfork Online - 52-Week High-Lows

May 20, 2013

Bits of Business | HealthSouth looks at sports injuries - Mcclatchy-Tribune Information Services -- Unrestricted

May 19, 2013

HealthSouth (HLS) Showing Bullish Technicals With Resistance At $30.29 - Freshbrewedmedia

May 16, 2013

Recent 52-Week High Exceeded in Shares of HealthSouth (HLS) - Financial News Netwfork Online - 52-Week High-Lows

May 16, 2013

Watch for Continued Gains in Shares of HealthSouth (HLS) - Financial News Netwfork Online - 52-Week High-Lows

May 14, 2013

Health Management Associates has the Best Relative Performance in the Health Care Facilities Industry (HMA, SKH, HLS, BKD, WOOF) - Financial News Network Online - News Corner

May 10, 2013

HealthSouth: The Winning Streak Continues (HLS) - Financial News Netwfork Online - 52-Week High-Lows

May 10, 2013

Shares of HLS Up 33.0% Since Uptrend Call on Shares - Comtex Smartrend(R)

May 10, 2013

See All News Stories on HLS

Broker Recommendations

Current ABR	1.91
ABR (Last Week)	1.91
# of recs in ABR	11
Average Target Price	28.70
Industry Rank by ABR	201 out of 265
Rank in Industry	1 out of 16

More HLS Broker Recommendations

Day Low - High	30.36 - 30.73
52wk Low - High	18.44 - 30.73
Previous Close	30.36
Avg. Volume	526,881
Industry	MED-OUTP/HM CRE
Market Cap	2.93 B
Div - Yield	0.00 - 0.00
Beta	1.64
PE (Forward)	17.29
Current Year Est.	1.76
Quarterly Earnings ESP	2.38%

PE (Forward)	17.29
PEG Ratio	1.28
Current Year Est.	1.76
Current Quarter Estimate	0.42
Most Accurate Estimate	0.43
Earnings ESP	2.38%
Next Earnings Report Date	07-25-2013
EPS Last Year	1.71
Expected Earnings Growth	13.50%

Username: Password:

Remember me [?]

Healthsouth Corp: (NYSE: HLS)

$30.59

0.23 (0.76%)

Volume 461,115

May 20 04:02 PM ET

Stock Activity

Premium research

Zacks Rank Short-Term: 1-3 Months

Zacks Recommendation Long-Term: 6+ Months

Zacks Industry Rank

Equity Research Report

Key Earnings Data

Company Description

Earnings Estimates

Industry Analysis

Sector:Medical>> Industry:MED-OUTP/HM CRE

Zacks Commentary

Financials

News

Broker Recommendations